Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-patient comparison of topical agents in atopic dermatitis
NCT02376049Phase 1Completed
- Sponsor
- LEO Pharma
- Start
- Feb 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, single-blind trial of Pimecrolimus vehicle + topical corticosteroid, betamethasone dipropionate spray 0.05% and clobetasol in atopic dermatitis (AD) (4 arms), sponsored by LEO Pharma. Primary endpoint: Total Sign Score change at 14 days. Started Feb 2015; status: completed.
02
Drugs
Pimecrolimus vehicle + topical corticosteroidbetamethasone dipropionate spray 0.05%clobetasol
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02376049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02376049.